Sweden · Delayed Price · Currency is SEK Haypp Group AB Earnings Call Transcripts
Fiscal Year 2025
-
Nicotine pouch volumes and net sales saw strong double-digit growth, driven by U.S. and U.K. markets, with infrastructure upgrades supporting rapid feature deployment. Investments in growth markets impacted EBIT, but long-term guidance targets robust revenue and margin expansion.
-
Nicotine pouch volumes and net sales saw strong double-digit growth, driven by U.S. and U.K. acceleration, with infrastructure upgrades supporting rapid feature deployment. Investments in growth markets impacted short-term margins, but long-term guidance targets robust revenue and EBIT expansion through 2028.
-
Nicotine pouch volumes and like-for-like sales saw double-digit growth, with the U.S. market driving operational gains and ZYN's return fueling a 60% year-over-year volume surge in October. Gross margin hit a record 18.8%, and investments are focused on U.S. expansion, with no dividend planned through 2028.
-
Nicotine pouch volumes and like-for-like sales grew strongly, with the U.S. market driving operational growth and Zyn sales resuming. Gross margin hit a record high, but investments in the U.S. kept EBIT margin flat. Guidance targets 18%-25% CAGR and 5.5% EBIT margin by 2028.
-
Nicotine pouch volumes grew 23% year-over-year, with revenue up 20% and gross margin rising to 19%. U.S. market expansion, emerging segment growth, and regulatory compliance drive performance, while heavy investment is expected to impact near-term earnings.
-
Nicotine pouch volumes and revenue grew strongly year-over-year, with gross margin up 5 points to 19%. Significant investments in the U.S. and growth markets are expected to impact short-term margins, while long-term guidance targets 18%-25% CAGR and 5.5% EBIT margin by 2028.
-
The presentation highlighted strong growth in risk-reduced nicotine products, with a focus on online sales, data-driven insights, and regulatory expertise. Strategic investments in the U.S. and continued innovation are expected to drive 18%-25% annual sales growth through 2028.
-
Nicotine pouch volumes grew 35% like-for-like, with gross margin up 4 points to 18%. U.S. and emerging segments drove strong sales, while heavy investment in the U.S. is expected to impact short-term earnings. Revenue CAGR of 18%-25% is targeted through 2028.
-
Dominating the online nicotine pouch market, the company leverages scale, compliance, and data-driven insights to drive rapid growth and profitability. With a focus on expanding in the U.S. and maintaining strong financials, it targets doubling revenue and quadrupling profit by 2028.
-
Nicotine pouches drive rapid growth, with the U.S. and U.K. as key expansion markets. Financial targets include 18%-25% annual sales growth and a 5.5% EBIT margin by 2028, supported by investments in technology, compliance, and local teams. The business leverages AI, automation, and data insights to maintain market leadership and scalability.
Fiscal Year 2024
-
Nicotine pouch volumes grew 37% year-over-year on a like-for-like basis in Q4, with gross margin up 4 points to 17%. Regulatory changes and new product launches are driving rapid U.S. market evolution, while strong growth in core and emerging segments supports a positive 2025 outlook.
-
Nicotine pouch volumes surged 42% year-over-year, driving 25% sales growth and an 81% increase in adjusted EBIT. Regulatory and legal challenges in Sweden and the U.S. were addressed, with SEK 11 million reserved for a San Francisco settlement. Margin expansion and infrastructure investments support a positive outlook.
-
Nicotine pouch volumes surged 43% year-over-year, driving 23% sales growth and margin expansion. Strong performance in growth and emerging markets, robust cash flow, and a solid balance sheet support the 2025 targets of SEK 5 billion revenue and 5%-7% EBIT margin.